Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qianjin Baoyun Pills in thyroid autoimmunity with recurrent miscarriage
ChiCTR2600125589Phase 4Recruiting
- Sponsor
- The Third Affiliated Hospital of Guangzhou Medical University
- Start
- May 2026
- Countries
- 1
01
Overview
Phase 4, randomised trial of Qianjin Baoyun Pills in autoimmune thyroid disease (AITD) and recurrent miscarriage (RPL) (2 arms), sponsored by The Third Affiliated Hospital of Guangzhou Medical University. Primary endpoint: Spontaneous abortion rate. Started May 2026; status: recruiting.
02
Drugs
Qianjin Baoyun Pills
03
Conditions
autoimmune thyroid disease (AITD)recurrent miscarriage (RPL)
Beyond the preview
Go deeper on ChiCTR2600125589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600125589.